Fig. 2From: Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trialsa Risk of bias summary: review authors' judgements about each risk of bias item for each included study. b Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studiesBack to article page